From: Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome
Dimension | Variable | Pre-Treatment Averagea | Post-Treatment Averagea | Test Statisticb | P |
---|---|---|---|---|---|
Sensory | Pain | 9 | 5 | 5.74 | < 0.001 |
Pain Relief | 9 | 5 | 5.11 | < 0.001 | |
Hours/Day in Pain | 22.97 | 17.42 | 4.27 | < 0.001 | |
Psychological | Depression | 8 | 5 | 4.32 | < 0.001 |
Quality of life | 9 | 6 | 4.94 | < 0.001 | |
Coping | 9 | 5 | 5.45 | < 0.001 | |
Dependency | 8 | 5 | 3.70 | < 0.001 | |
Sociological | Sleep | 9 | 5 | 5.20 | < 0.001 |
Work | 10 | 10 | 2.63 | NS | |
Social Life | 10 | 7 | 4.81 | < 0.001 | |
Sex Life | 9 | 7.5 | 3.36 | < 0.001 | |
Driving | 6.5 | 4.5 | 3.77 | < 0.001 | |
Housework | 8 | 7 | 4.18 | < 0.001 | |
Mobility | 9 | 7 | 4.22 | < 0.001 |